Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

By Recker F.   Kwiatkowski M.K.   Piironen T.   Pettersson K.   Huber A.   Lummen G.   Tscholl R.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 481-485

Elsevier

Access to resources Recommend Favorite

Clinical implications of free-to-total immunoreactive prostate-specific antigen ratios

By Wymenga L. F. A.   Duisterwinkel F. J.   Groenier K.   Brummen P. Visser-van   Marrink J.   Mensink H. J. A.  

Scandinavian Journal of Urology and Nephrology, Vol. 34, Iss. 3, 2000-08 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

By Chen Y.-T.   Luderer A.A.   Thiel R.P.   Carlson G.   Cuny C.L.   Soriano T.F.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 518-524

Elsevier

Access to resources Recommend Favorite

Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4–10 ng/ml

By Martínez-Piñeiro L.  

World Journal of Urology, Vol. 22, Iss. 2, 2004-06 ,pp. : 124-131

Springer Publishing Company

Access to resources Recommend Favorite